Washington

Mixedstatus since reviewed

Psilocybin has mixed legal status in Washington. Possession is a gross misdemeanor statewide; a state-funded university pilot offers therapy only through FDA-approved pathways.1

1. What the law is

Governor Inslee signed the psilocybin pilot and vetoed its machinery. What survived 2SSB 5263 on May 9, 2023 is a University of Washington therapy services pilot for first responders and veterans; the psilocybin advisory board and the Department of Health's rulemaking authority did not. The legislature has funded the pilot, with $1,464,000 in the 2023-25 operating budget and $730,000 in the 2025-27 budget, and it may only offer services through pathways the FDA has approved. Statewide, psilocybin and psilocyn are Schedule I under RCW 69.50.204, and knowing possession is a gross misdemeanor under RCW 69.50.4013. Five local jurisdictions have made enforcement their lowest priority, Seattle and Port Townsend in 2021, Jefferson County in 2023, Olympia in 2024 and Tacoma in 2025, but those resolutions bind nobody and change no law.

Washington occupies a middle position among US states: psilocybin remains prohibited under state law, but the state has enacted a narrow clinical pathway and several of its local governments have formally stepped back from enforcement. The enacted track is SB 5263, signed by Governor Jay Inslee on May 9, 2023, which created a state psilocybin task force and authorized a psilocybin therapy pilot program at the University of Washington serving military veterans and first responders. The pilot does not legalize psilocybin for the general public; possession, cultivation, and sale outside the program remain prohibited statewide. The second track is local. Beginning with Seattle in October 2021, then the largest US city to deprioritize psilocybin enforcement, a succession of jurisdictions have adopted resolutions making entheogen-related investigations and arrests their lowest law-enforcement priority: Port Townsend (2021), Jefferson County (2023), Olympia (2024), and Tacoma (2025). These resolutions are policy statements; state statutes continue to apply within those jurisdictions. Together the two tracks define Washington's current posture: a tightly scoped clinical pilot at the state level, and spreading enforcement discretion at the local level.

Washington's approach contrasts with Oregon's next door, where voters approved a regulated psilocybin services program by ballot initiative in 2020. Washington's legislature has moved incrementally, from a task force and clinical pilot in 2023 toward broader access bills that have so far stalled. The most recent, SB 5921, the Washington Medical Psilocybin Act, cleared the Senate Health and Long-Term Care Committee on February 3, 2026, but stalled in Ways and Means past the fiscal cutoff and is dead for the 2026 session. Supporters would need to reintroduce the measure in 2027; in the near term, movement is more likely to continue through local deprioritization resolutions than through state law.

2. Trials in Washington

Interventional psilocybin trials with at least one site in Washington, as their sponsors filed them with ClinicalTrials.gov, EU CTIS, ISRCTN and ANZCTR. Each row links to the registry record, which sets out who may take part.

2Recruiting or opening
5Active
4Completed
0Closed
11Total

Recruiting or opening counts trials recruiting now, not yet recruiting, or enrolling by invitation. Closed counts trials terminated, suspended, withdrawn or left unverified by their sponsors.

Registry data as of Nov 2026. The table shows all 11 trials, those recruiting now first, then the others, latest start date first within each. This site makes no medical claims about psilocybin.
NCT07226232Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression (opens in new tab)Recruiting at VA Puget Sound Health Care System Seattle Division, Seattle, WAPhase Phase 3Sponsor VA Office of Research and DevelopmentStatus RecruitingStart date
NCT06793397A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder (opens in new tab)Recruiting at Seattle Neuropsychiatric Treatment Center, SeattlePhase Phase 3Sponsor Cybin IRL LimitedStatus RecruitingStart date
NCT07336238Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies (opens in new tab)Site at Fred Hutch/University of Washington Cancer Consortium, SeattlePhase Phase 2Sponsor University of WashingtonStatus Active, not recruitingStart date
NCT06853912PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD) (opens in new tab)Site at University of Washington Center for Novel Therapeutics in Addiction Psychiatry, SeattlePhase Phase 2Sponsor Nathan Brashares SackettStatus Active, not recruitingStart date
NCT06644170A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer (opens in new tab)Site at Fred Hutch/University of Washington Cancer Consortium, SeattlePhase Phase 1Sponsor University of WashingtonStatus CompletedStart date
NCT06308653Psilocybin for Major Depressive Disorder (MDD) (opens in new tab)Sites in Bellevue and VancouverPhase Phase 3Sponsor Usona InstituteStatus Active, not recruitingStart date
NCT05847686Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer (opens in new tab)Site at Fred Hutch/University of Washington Cancer Consortium, SeattlePhase Phase 1/2Sponsor University of WashingtonStatus CompletedStart date
NCT05711940Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD (opens in new tab)Site at Seattle Neuropsychiatric Treatment Center, SeattlePhase Phase 3Sponsor COMPASS PathwaysStatus Active, not recruitingStart date
NCT05624268Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD (opens in new tab)Site at Core Clinical Research, EverettPhase Phase 3Sponsor COMPASS PathwaysStatus CompletedStart date
NCT04982796Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder (opens in new tab)Site at Portland VA Health Care System, VancouverPhase Phase 1/2Sponsor Portland VA Research Foundation, IncStatus Active, not recruitingStart date
NCT05163496Frontline Clinician Psilocybin Study (opens in new tab)Site at University of Washington, SeattlePhase Phase 3Sponsor University of WashingtonStatus CompletedStart date

ClinicalTrials.gov data courtesy of the U.S. National Library of Medicine.

3. History

The legal events behind this entry, dated and oldest first. Our own reviews and corrections are listed under Changes to this record.

  1. Seattle City Council unanimously adopts Resolution 32021 (October 4), declaring entheogen-related investigations and arrests among the city's lowest enforcement priorities; Seattle was the largest US city to take this step at the time.

    Port Townsend City Council unanimously adopts Resolution 21-088, making enforcement against entheogen-related activities a low priority for the city.

  2. Jefferson County Board of Commissioners passes a resolution (May 1) deprioritizing county enforcement against entheogens.

    Governor Jay Inslee signs SB 5263 (May 9), creating a state psilocybin task force and authorizing a University of Washington psilocybin therapy pilot for veterans and first responders.

    Mixed status takes effect.

  3. Olympia City Council unanimously adopts a resolution (August 13) making entheogen enforcement the city's lowest law-enforcement priority.

  4. Tacoma City Council unanimously adopts a resolution (January 28) deprioritizing entheogen enforcement and expressing support for statewide decriminalization.

  5. SB 5921, the Washington Medical Psilocybin Act, passes the Senate Health and Long-Term Care Committee (February 3) and is referred to Ways and Means (February 4), where it stalls past the fiscal cutoff; the bill is dead for the 2026 session.

4. Proposed laws

No proposed law is on file in Washington that would change this entry, as of the 20 Oct 2026 review.

5. Common questions

Are magic mushrooms ("shrooms") legal in Washington?

"Magic mushrooms" and "shrooms" are common names for fungi that contain psilocybin, and this entry states the law on psilocybin itself, which some laws treat separately from the fungus. Psilocybin has mixed legal status in Washington. Possession is a gross misdemeanor statewide; a state-funded university pilot offers therapy only through FDA-approved pathways.

Read the law

RCW 69.50.204(c)(28)-(29) (psilocybin and psilocyn, Schedule I); RCW 69.50.4013(2)(a) (knowing possession, a gross misdemeanor). 2SSB 5263 (2023), chapter 364, Laws of 2023, partial veto: approved May 9, 2023 with sections 1, 2, 3, 4, 5, 7, 10, 11 and 13 vetoed; effective July 23, 2023. What survived: a Health Care Authority psilocybin task force that expired June 30, 2024, and, in section 8, a University of Washington psilocybin therapy services pilot program for first responders and veterans, limited to pathways approved by the FDA and established subject to appropriation. Appropriated to the University of Washington from the workforce education investment account: $1,464,000 in the 2023-25 operating budget (ESSB 5187, chapter 475, Laws of 2023, section 606(85)) and $730,000 in the 2025-27 operating budget (ESSB 5167, chapter 424, Laws of 2025, section 606(50)). City and county deprioritizations: Seattle (2021), Port Townsend (2021), Jefferson County (2023), Olympia (2024), Tacoma (2025).1

Sources

This entry's status is checked against the primary sources below, and the methodology explains how each entry is graded for confidence.

  1. 1.lawfilesext.leg.wa.gov (opens in new tab) · lawfilesext.leg.wa.gov
  2. 2.app.leg.wa.gov (opens in new tab) · app.leg.wa.gov

This entry is for information only and is not legal or medical advice. Laws change, and enforcement can differ from the letter of the law, so check the current position against the primary sources above before relying on it.

Changes to this record

4 changes on file, the latest on . Show all

Every change we have made to this record, dated, corrections included. Nothing changes silently.

  1. Correction

    Washington is now recorded as mixed. Possessing psilocybin is still a gross misdemeanor statewide, and our earlier reading rested on five city and county resolutions that ask local police to make enforcement their lowest priority, which change no state law. The state also funds a University of Washington pilot that offers psilocybin therapy only through FDA-approved pathways.

  2. Review confirmed

    Washington was checked again on 21 September 2026 and nothing has moved. The 2023 law behind the University of Washington pilot, and the state statutes that keep possession a gross misdemeanor, read as this entry says.

  3. Correction

    Washington's record now cites the 2023 session law itself. That act was a partial veto which struck the advisory board and the health department's rulemaking authority, and it took effect July 23, 2023.

  4. Review confirmed

    Washington's status held. The medical program bill SB 5921 got further than earlier attempts and then died in the Ways and Means committee in February 2026.

Cite this recordUS-WA-001

Psilocybin Media Group. "Washington: psilocybin legal status." The Psilocybin Record, accession US-WA-001, version of 20 Oct 2026. https://psilocybinlegalization.com/record/washington

Record 103 of 106 · Last reviewed US-WA-001